The present invention discloses novel highly bioavailable, water soluble, sustained release nanoformulation(s) comprising unique proportion of the hydrophobic plant derived compound(s) in an emulsifier phase and aqueous phase to achieve the sustained release over a 24hr time period and more. The present invention fu...

The present invention discloses a composition(s) of hydrophobic plant molecule(s) and/or extract(s) with enhanced bioavailability comprising hydrophobic active and synergetic combination of lecithin and lysolecithin and to the process for preparation thereof.

A pharmaceutical composition(s) for ophthalmic/nasal administration comprising; one or more nano emulsified Curcumin component(s) and/or its metabolites selected from natural or synthetic curcuminoid(s); in combination with a pharmaceutically acceptable excipient(s), effective in increasing the bioavailability of th...

Aqueous ophthalmic compositions comprising natural or synthetic curcuminoids either alone or in combination, nonionic surfactant and co-solvent alongwith suitable ophthalmic excipients, effective in increasing the bioavailability of the active compounds when administered topically to the eye is disclosed herein. ...

A process for nanomulsification of highly lipophillic polyphenolic compounds using non-ionic surfactant and a non-ionic co-solvent with the help of sonar energy, to enhance the aqueous solubility is disclosed herein.